PATENT CLAIM ANALYSIS

Application Number: 15762630
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "440000"]

Abstract:
The present invention describes ophthalmic lipoic acid choline ester compositions and specific processes to produce biocompatible formulations of said compositions suitable for the eye.

Claim (Index 8):
A method of producing the pharmaceutical composition according to any one of  claims 1 - 7 , comprising:\n finely grinding the pharmaceutically acceptable salt of lipoic acid choline ester, adding the ground salt to water, wherein the water has less than 5 ppm, preferably less than 2 ppm of oxygen, mixing for 6 to 8 hours, preferably for 8 hours, at room temperature, to form a mixture, filling an ophthalmic bottle with the mixture and adding an inert gas overlay before capping, packaging the filled-and-capped ophthalmic bottle in a gas-impermeable pouch, and storing the package at 2-8\u00b0 C.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14525471', '12815526', '13311716', '12888117', '12841414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6707531654453257
- 35 USC 102 Novelty (BERT): 0.51049406103828
- Combined Prediction Score: 0.6547272550046211
- Mean Citation Score: 171.36050600000004
- Max Citation Score: 183.26176
- Similarity Product: 105.42214117858887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test